Vincent Costalat Selected Research

Thrombosis (Thrombus)

4/2023	Negative susceptibility vessel sign might be predictive of complete reperfusion in patients with acute basilar artery occlusion managed with thrombectomy.
3/2023	Efficacy and safety of low dose intravenous cangrelor in a consecutive cohort of patients undergoing neuroendovascular procedures.
1/2023	Frontline thrombectomy strategy and outcome in acute basilar artery occlusion.
8/2022	Endovascular treatment of ischemic stroke due to isolated internal carotid artery occlusion: ETIS registry data analysis.
1/2022	Effects of the flow diversion technique on nucleotide levels in intra-cranial aneurysms: A feasibility study providing new research perspectives.
1/2021	Distal anterior cerebral artery aneurysms treated with flow diversion: experience of a large-volume center and systematic review of the literature.
1/2020	Acute thromboses and occlusions of dual layer carotid stents in endovascular treatment of tandem occlusions.
1/2019	Thrombus Length Predicts Lack of Post-Thrombolysis Early Recanalization in Minor Stroke With Large Vessel Occlusion.
1/2019	Better Collaterals Are Independently Associated With Post-Thrombolysis Recanalization Before Thrombectomy.
1/2018	Similar Outcomes for Contact Aspiration and Stent Retriever Use According to the Admission Clot Burden Score in ASTER.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Vincent Costalat Research Topics

Disease

52	Ischemic Stroke 05/2024 - 01/2012
47	Stroke (Strokes) 05/2024 - 07/2011
15	Aneurysm (Aneurysms) 10/2023 - 10/2009
13	Thrombosis (Thrombus) 04/2023 - 12/2010
12	Infarction (Infarctions) 05/2024 - 01/2018
11	Intracranial Aneurysm (Cerebral Aneurysm) 03/2024 - 04/2015
9	Cerebral Infarction 12/2023 - 01/2017
7	Intracranial Hemorrhages (Intracranial Hemorrhage) 08/2022 - 01/2018
5	Pathologic Constriction (Stenosis) 10/2023 - 10/2011
4	Cerebral Hemorrhage 05/2024 - 01/2019
4	Ruptured Aneurysm 07/2023 - 10/2013
2	Rupture 01/2021 - 01/2018
1	Headache (Headaches) 04/2024
1	Inflammation (Inflammations) 03/2024
1	Arterial Occlusive Diseases (Arterial Occlusive Disease) 10/2023
1	Arteriovenous Malformations (Arteriovenous Malformation) 04/2023
1	Intracranial Arteriosclerosis (Cerebral Atherosclerosis) 04/2023
1	Atherosclerosis 04/2023
1	Hemorrhage 03/2023
1	Intracranial Embolism 08/2022
1	Atrial Fibrillation 01/2022
1	Neurologic Manifestations (Neurological Manifestations) 08/2021
1	COVID-19 01/2021
1	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 01/2021
1	Thromboembolism 10/2020
1	Hypercapnia 01/2020
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2020
1	Mucopolysaccharidosis II (Hunter Syndrome) 10/2018

Drug/Important Bio-Agent (IBA)

4	Biomarkers (Surrogate Marker)IBA 03/2024 - 01/2016
3	AnticoagulantsIBA 05/2024 - 10/2018
3	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 07/2023 - 01/2021
3	PlatinumIBA 01/2018 - 06/2015
3	HydrogelsIBA 01/2018 - 06/2015
1	trans-sodium crocetinate (crocetin)IBA 05/2024
1	Anesthetics (Anesthetic Agents)IBA 04/2024
1	Interleukin-6 (Interleukin 6)IBA 03/2024
1	danaparoid (Orgaran)FDA Link 06/2023
1	TicagrelorIBA 05/2023
1	APTIBA 05/2023
1	ElementsIBA 05/2023
1	Clopidogrel (Plavix)FDA Link 05/2023
1	FibrinIBA 04/2023
1	cangrelorIBA 03/2023
1	Vitamin K FDA Link 01/2022
1	Adenosine Diphosphate (ADP)IBA 01/2022
1	Adenosine Triphosphate (ATP)IBA 01/2022
1	NucleotidesIBA 01/2022
1	Adenosine Monophosphate (AMP)IBA 01/2022
1	Tissue Plasminogen Activator (Alteplase)FDA Link 11/2021
1	mesoglycanIBA 08/2021
1	Aspartic Acid (Aspartate)FDA Link 01/2021
1	Heparin (Liquaemin)FDA LinkGeneric 01/2020
1	ProteomeIBA 01/2020
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2020
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 01/2019

Therapy/Procedure

62	Thrombectomy 05/2024 - 07/2011
30	Stents 03/2024 - 12/2010
26	Therapeutics 05/2024 - 01/2012
7	Retreatment 10/2023 - 10/2009
6	Endovascular Procedures 01/2021 - 01/2017
5	Punctures 06/2023 - 09/2021
3	Catheters 01/2022 - 06/2020
2	Conservative Treatment 04/2023 - 10/2020
1	Aftercare (After-Treatment) 04/2024
1	Decompressive Craniectomy 07/2023
1	Critical Care (Surgical Intensive Care) 01/2021
1	Artificial Respiration (Mechanical Ventilation) 01/2021
1	Decompression 10/2018
1	Surgical Decompression 10/2018
1	Secondary Prevention 01/2017